 |
||||
|
||||
|
||||
|
||||
This Article Full Text Full Text (PDF) Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager 
Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lee, J.-Y. Articles by Koh, J.-Y. Search for Related Content PubMed PubMed Citation Articles by Lee, J.-Y. Articles by Koh, J.-Y. Pubmed/NCBI databases
Compound via MeSH
Hazardous Substances DB Medline Plus Health Information
Previous Article | Next Article
The Journal of Neuroscience, 2001, 21:RC171:1-6
RAPID COMMUNICATION
Protection by Pyruvate against Transient Forebrain Ischemia in RatsJoo-Yong Lee, Yang-Hee Kim, and Jae-Young Koh National Creative Research Initiative Center for the Study of CNS Zinc and Department of Neurology, University of Ulsan College of Medicine, Seoul 138-736, Korea
Pyruvate has a remarkable protective effect against zinc neurotoxicity. Because zinc neurotoxicity is likely one of the key mechanisms of ischemic brain injury, the neuroprotective effect of pyruvate was tested in a rat model of transient forebrain ischemia. Control experiments in mouse cortical culture showed that pyruvate almost completely blocked zinc toxicity but did not attenuate calcium-overload neuronal death. Adult rats subjected to 12 min forebrain ischemia exhibited widespread zinc accumulation and neuronal death throughout hippocampus and cortex 72 hr after reperfusion. However, rats injected intraperitoneally with sodium pyruvate (500-1000 mg/kg) within 1 hr after 12 min forebrain ischemia showed almost no neuronal death. In addition, the mortality was markedly decreased in the pyruvate-protected groups (3.8%) compared with the NaCl-injected control group (58.1%). The neuroprotective effect persisted even at 30 d after the insult. The spectacular protection without noticeable side effects makes pyruvate a promising neuroprotectant in human ischemic stroke.
Key words: zinc neurotoxicity; glycolysis; excitotoxicity; glutamate antagonist; stroke; ATP; NAD+
Copyright © Society for Neuroscience 0270-6474//$05.00/0
This article has been cited by other articles:
E. Hinoi, T. Takarada, Y. Tsuchihashi, S. Fujimori, N. Moriguchi, L. Wang, K. Uno, and Y. Yoneda
A Molecular Mechanism of Pyruvate Protection against Cytotoxicity of Reactive Oxygen Species in Osteoblasts
Mol. Pharmacol., September 1, 2006; 70(3): 925 - 935.
[Abstract] [Full Text] [PDF]
Y.-M. Yu, J.-B. Kim, K.-W. Lee, S. Yun Kim, P.-L. Han, and J.-K. Lee
Inhibition of the Cerebral Ischemic Injury by Ethyl Pyruvate With a Wide Therapeutic Window
Stroke, October 1, 2005; 36(10): 2238 - 2243.
[Abstract] [Full Text] [PDF]
S. W. Suh, K. Aoyama, Y. Matsumori, J. Liu, and R. A. Swanson
Pyruvate Administered After Severe Hypoglycemia Reduces Neuronal Death and Cognitive Impairment
Diabetes, May 1, 2005; 54(5): 1452 - 1458.
[Abstract] [Full Text] [PDF]
X. Q. Wang, A. Y. Xiao, C. Sheline, K. Hyrc, A. Yang, M. P. Goldberg, D. W. Choi, and S. Ping Yu
Apoptotic insults impair Na+, K+-ATPase activity as a mechanism of neuronal death mediated by concurrent ATP deficiency and oxidant stress
J. Cell Sci., May 15, 2003; 116(10): 2099 - 2110.
[Abstract] [Full Text] [PDF]
|
|
|
|
 |
|